Alan J. Lewis
Chairman bei NeuraMetrix, Inc.
Profil
Alan J.
Lewis currently works at Batu Biologics, Inc., as Chairman from 2015, NeuraMetrix, Inc., as Chairman, Rincon Pharmaceuticals, Inc., as Director, Sosei Co. Ltd., as Director, Scancell Ltd., as Director, BIOCOM, as Director, Targazyme, Inc., as Director from 2010, Capella Therapeutics, Inc., as Director, and Habit DX, Inc., as Director.
Dr. Lewis also formerly worked at Signal Pharmaceuticals, Inc., as President & Chief Executive Officer from 1994 to 2000, Medistem, Inc., as Chief Executive Officer & Director from 2012 to 2014, ViaCyte, Inc., as President & Chief Executive Officer in 2008, Ambit Biosciences Corp., as President, Chief Executive Officer & Director in 2011, DiaVacs, Inc., as President, Chief Executive Officer & Director, Novocell, Inc. (Old), as President & Chief Executive Officer from 2006 to 2008, Juvenile Diabetes Research Foundation Ltd., as President & Chief Executive Officer in 2010, Signal Therapeutics, Inc., as Chief Executive Officer, Cytochroma, Inc., as Chairman, LymphoSign, Inc., as Chairman, Novation Pharmaceuticals, Inc., as Chairman, BioMarin Pharmaceutical, Inc., as Independent Non-Executive Director from 2014 to 2020, Discovery Partners International, Inc., as Director, Biotica Technology Ltd., as Non-Executive Director in 2013, Sosei Group Corp., as Non-Executive Director, Scancell Holdings Plc, as Non-Executive Director from 2016 to 2020, Cellastra, Inc., as Director, Assembly Biosciences, Inc., as Independent Director from 2015 to 2020, Yale University, as Research Associate from 1972 to 1973, Celgene Research & Development Co. LLC, as President from 2000 to 2006, Wyeth-Ayerst Research, as Vice President-Research from 1979 to 1994, and Wyeth Laboratories, Inc., as Principal.
Dr. Lewis received his undergraduate degree from The University of Southampton and doctorate degree from The University of Wales.
Aktive Positionen von Alan J. Lewis
| Unternehmen | Position | Beginn |
|---|---|---|
Sosei Co. Ltd.
 Sosei Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sosei Group Corp., Sosei Co. Ltd. is a world-leader in GPCR medicine design and development. The private company is based in Tokyo, Japan. The Japanese company obtains and maintains intellectual property rights to protect its innovations and technologies. | Director/Board Member | - |
Rincon Pharmaceuticals, Inc.
 Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rincon Pharmaceuticals, Inc. develops human therapeutic proteins. It develops and manufactures both partnered and proprietary products. The company was founded by Bruce D. Steel in 2004 and is headquartered in San Diego, CA. | Director/Board Member | - |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Director/Board Member | - |
Targazyme, Inc.
 Targazyme, Inc. BiotechnologyHealth Technology Targazyme, Inc. operates as a biotechnology company. It develops and commercializes breakthrough products. The firm offers products for stem cell transplantation, immunotherapy for cancer, regenerative medicine, and gene therapy. The company was founded by Lynnet Koh and is headquartered in Carlsbad, CA. | Director/Board Member | 01.01.2010 |
Batu Biologics, Inc.
 Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA. | Chairman | 01.01.2015 |
Capella Therapeutics, Inc.
 Capella Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capella Therapeutics, Inc. develops small molecule drugs to treat cancer and inflammatory diseases. The private company is based in San Diego, CA. The company was founded in 2014 by Yun Long. Yun Long has been the CEO since 2014. | Director/Board Member | - |
Scancell Ltd.
 Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Director/Board Member | - |
Habit DX, Inc.
 Habit DX, Inc. Medical SpecialtiesHealth Technology Habit DX, Inc. manufactures clinical measuring and monitoring tools. The private company is based in San Francisco, CA. | Director/Board Member | - |
NeuraMetrix, Inc.
 NeuraMetrix, Inc. Electronic Equipment/InstrumentsElectronic Technology NeuraMetrix, Inc. manufactures clinical measurement tools for monitoring brain health. The company was founded by Jan Samzelius and Christian Olsson in 2012 and is headquartered in Palo Alto, CA. | Chairman | - |
Ehemalige bekannte Positionen von Alan J. Lewis
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Alan J. Lewis
| The University of Southampton | Undergraduate Degree |
| The University of Wales | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| NXERA PHARMA CO., LTD. | Health Technology |
| SCANCELL HOLDINGS PLC | Health Technology |
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 26 |
|---|---|
Signal Pharmaceuticals, Inc.
 Signal Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Signal Pharmaceuticals Inc is pioneering the discovery and development of small molecule therapeutics which regulate the transcription factors involved in the progression of a number of inflammatory, viral and neurological diseases. The core technology for the company's research was discovered in the laboratories of three of its founders, and has been licensed from the University of California and the Salk Institute. (SB) It was located in San Diego, CA. | Commercial Services |
Discovery Partners International, Inc.
 Discovery Partners International, Inc. Miscellaneous Commercial ServicesCommercial Services Discovery Partners International, Inc. (DPI) used to research laboratory looking to discovery pharmaceutical products. It was a small molecule and natural product based drug discovery company that offered collaborations and services complementing the internal capabilities of pharmaceutical and biopharmaceutical. Discovery Partners has actively contributed to dozens of drug discovery collaborations. The company had operations in United States and Europe. The company was founded in 1995 was headquartered in San Diego, CA | Commercial Services |
Medistem, Inc.
 Medistem, Inc. Medical SpecialtiesHealth Technology Medistem, Inc. is focused on developing therapies for treating serious diseases and conditions using the natural regenerative properties of stem cells. Endometrial Regenerative Cell possess specialized abilities to stimulate new blood vessel growth and can differentiate into lung, liver, heart, brain, bone, cartilage, fat and pancreatic tissue. The company was founded by Neil H. Riordan in October 2005, and is headquartered in San Diego, CA. | Health Technology |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Biotica Technology Ltd.
 Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | Health Technology |
Cytochroma, Inc.
 Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada. | Health Technology |
Rincon Pharmaceuticals, Inc.
Rincon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rincon Pharmaceuticals, Inc. develops human therapeutic proteins. It develops and manufactures both partnered and proprietary products. The company was founded by Bruce D. Steel in 2004 and is headquartered in San Diego, CA. | Health Technology |
DiaVacs, Inc.
 DiaVacs, Inc. BiotechnologyHealth Technology DiaVacs, Inc. develops and commercializes cell-based therapies for the treatment of type 1 diabetes. The company is based in La Jolla, CA. The company was founded by Dietrich A. Stephan, Nick Giannoukakis, and David L. Finegold. Alan J. Lewis has been the CEO of the company since 2015. | Health Technology |
Batu Biologics, Inc.
Batu Biologics, Inc. Pharmaceuticals: MajorHealth Technology Batu Biologics, Inc. operates as an immunotherapy company. It develops therapeutics that addresses the multi-factorial and multi-dimensional nature of cancer. The company was founded by Samuel C. Wagner, Thomas Ichim and Dimitri Theofilopoulos and is headquartered in San Diego, CA. | Health Technology |
Sosei Co. Ltd.
Sosei Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Sosei Group Corp., Sosei Co. Ltd. is a world-leader in GPCR medicine design and development. The private company is based in Tokyo, Japan. The Japanese company obtains and maintains intellectual property rights to protect its innovations and technologies. | Commercial Services |
Scancell Ltd.
Scancell Ltd. Miscellaneous Commercial ServicesCommercial Services Scancell Ltd. researches and develops techniques for isolating foetal cells from a maternal blood sample. The company was founded by Lindy Durrant in 1997 and is headquartered in Nottingham, the United Kingdom. | Commercial Services |
LymphoSign, Inc.
 LymphoSign, Inc. BiotechnologyHealth Technology LymphoSign, Inc. develops drugs for the cancer treatment. It also develops drugs acting on signaling pathways involved in the progression of acute leukemias, lymphomas and solid tumors. The company was founded by Chaim Roifman in 2000 and is headquartered in Markham, Canada. | Health Technology |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
Celgene Research & Development Co. LLC
 Celgene Research & Development Co. LLC Pharmaceuticals: MajorHealth Technology Celgene Research & Development manufactures biopharmaceutical products. It develops discovery programs that regulate inflammatory, cardiovascular, neurological diseases, and cancer. It is a subsidiary of Celgene Corp. The company is headquartered in San Diego, CA. | Health Technology |
Novation Pharmaceuticals, Inc.
 Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada. | Health Services |
| Wyeth-Ayerst Research | |
Targazyme, Inc.
Targazyme, Inc. BiotechnologyHealth Technology Targazyme, Inc. operates as a biotechnology company. It develops and commercializes breakthrough products. The firm offers products for stem cell transplantation, immunotherapy for cancer, regenerative medicine, and gene therapy. The company was founded by Lynnet Koh and is headquartered in Carlsbad, CA. | Health Technology |
| Novocell, Inc. (Old) | Health Technology |
Juvenile Diabetes Research Foundation Ltd.
 Juvenile Diabetes Research Foundation Ltd. Miscellaneous Commercial ServicesCommercial Services Juvenile Diabetes Research Foundation Ltd. is a British company that engages in the prevention, treatment, causes, and cure for diabetes. The CEO of the non-profit company is Karen Addington. | Commercial Services |
| Wyeth Laboratories, Inc. | |
Cellastra, Inc.
 Cellastra, Inc. BiotechnologyHealth Technology The American company was founded by Karl L. Mettinger and Kent Persson, with Karl L. Mettinger serving as CEO since incorporation. | Health Technology |
Capella Therapeutics, Inc.
Capella Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capella Therapeutics, Inc. develops small molecule drugs to treat cancer and inflammatory diseases. The private company is based in San Diego, CA. The company was founded in 2014 by Yun Long. Yun Long has been the CEO since 2014. | Commercial Services |
| Signal Therapeutics, Inc. | |
Habit DX, Inc.
Habit DX, Inc. Medical SpecialtiesHealth Technology Habit DX, Inc. manufactures clinical measuring and monitoring tools. The private company is based in San Francisco, CA. | Health Technology |
NeuraMetrix, Inc.
NeuraMetrix, Inc. Electronic Equipment/InstrumentsElectronic Technology NeuraMetrix, Inc. manufactures clinical measurement tools for monitoring brain health. The company was founded by Jan Samzelius and Christian Olsson in 2012 and is headquartered in Palo Alto, CA. | Electronic Technology |
